| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |